Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
Keep the sparks coming! Delegates of the conference have access to on-demand content until the end of October 2021.
This brand-new publication offers a guide through the complex landscape of regulations, standards, and interpretations surrounding software as a medical device.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 08 February 2012 | By Alexander Gaffney, RAC
The 510(k) approval process used by North Carolina company TearScience could represent a new and imitable strategy for other companies to follow, said TearScience CEO Tim Willis in remarks to Med City News on 7 February.
The company's device, the LipiFlow Thermal Pulsation System, is used to treat dry eye by clearing channels that supply the eye with moisture-retaining oils.
The company applied for 510(k) clearance in two separate filings, and received clearance from the US Food and Drug Administration just seven months after their initial filing.
"If you tried to do both of these filings (at once), especially in this regulatory environment, I doubt we'd get cleared by now," said Willis.
The FDA's 510(k) process is used by companies to prove "substantial equivalence" to existing medical devices in lieu of conducting time consuming and costly clinical trials to prove a device's safety and efficacy.
"In hopes of speeding things along, the company made an initial filing for the part of LipiFlow that treats the patient - the disposable piece that is used on the patient's eye," wrote MedCity News. "After that part received FDA clearance, the company filed its application for what the physician uses including upgraded software and a handheld unit. It's the full unit that TearScience will be marketing in the United States."
Tags: Filing, TearScience, Latest News, 510(k), approval
Regulatory Focus newsletters
All the biggest regulatory news and happenings.